Vodori, a Chicago, Ill. based cloud software provider for life science companies, has raised $ 7.5 million in Series A funding.
The round was led by Baird Capital with the participation of some existing investors.
In addition to the funding, Jim Pavlik, partner of Baird Capital’s venture capital team, will join Vodori’s board of directors, alongside current directors Brian Parker, Jim Hussey, Richard Gochnauer and Scott Rovegno.
The company intends to use the funds to continue to expand its business and commercial reach.
Led by Scott Rovegno, CEO and Co-Founder, Vodori provides Pepper CloudÂ® The suite of products, which streamlines and automates the way life science companies deliver critical content to key audiences including patients, healthcare providers and key thought leaders, is a company of life sciences industry that rapidly brings life-saving drugs, vaccines, medical devices and diagnostic solutions to market. The connected platform modernizes content review, sales and MSL activation, and delivers timely analytics to optimize critical processes.
The Pepper Cloud product suite is used by thousands of life science professionals in more than 50 countries around the world. Clients represent a variety of pharmaceutical, biotechnology, diagnostic and medical device companies, including Biocartis, Progenity, Tris Pharma and Generate Life Sciences.